The end to WHAT controversy?

In an extraordinary editorial in the July issue of the Journal of Urology, Dr. Michael Koch of the University of Indiana School of Medicine makes the following statement: … READ MORE …

Is standardization of the PSA cutpoint for biochemical recurrence after surgery a good idea?

A paper just published in this month’s issue of the Journal of Urology has suggested that the true cutpoint for PSA levels indicative of biochemical recurrence in the highest number of patients is actually 0.4 ng/ml (as opposed to the oft-stated 0.2 ng/ml). … READ MORE …

Can new forms of robotic technology transform RALP experience?

For the past 15 or so years, the daVinci brand of surgical robot, developed and made by Intuitive, has dominated the marketplace for surgical robots. However, changes are coming that may challenge that effective monopoly. … READ MORE …

Columnist calls on urologists to disclose prostatectomy rates and related data

In one of his regular video columns on the Medscape web site, Dr. Gerald Chodak has called on his colleagues in the urology community to voluntarily disclose data about their prostatectomy experience to patients interested in surgical treatment for localized prostate cancer. … READ MORE …

Just “delaying” surgery does increase risk … but it’s not active surveillance

A key question for men diagnosed with low-risk prostate cancer is always going to be whether, and for how long, they can defer treatment without increasing the risk that delayed treatment will be less effective (or riskier) in some ways. … READ MORE …

Better cancer control with radiation vs. surgery in high-risk patients

Researchers at the University of Alabama at Birmingham assigned high-risk patients to receive either external beam radiation therapy with androgen deprivation therapy (RT + ADT) or to receive surgery (RP) with or without adjuvant/salvage radiation. … READ MORE …

A look back at PIVOT … with additional data for context

Five years ago now, in May 2011, Wilt first presented the results of the PIVOT trial at the annual meeting of the American Urological Association in Washington, DC. A bit over a year later, the final results were published in the New England Journal of Medicine. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,447 other followers